from the association
NEW IN REVIEW
D-H, Zacharski LR, Jacobs DR. 1247e1-1247e7.
IN THIS ISSUE PERIODICALS
1497
PRACTITIONER’S BOOKSHELF
1504
SITES IN REVIEW
1506
THE AMERICAN JOURNAL OF CLINICAL NUTRITION Vol 83, June 2006 (www.ajcn.org) Œ
PERIODICALS Periodical articles of special interest to nutrition professionals are cited or abstracted in this section. Articles that have been abstracted are marked with a darkened circle (●). Literature abstracts and citations are prepared by the Journal editors. Articles are selected from scientific and professional publications chosen to convey fundamental knowledge in nutritional science and to span the specialty practice fields of readers. A list of the publications reviewed for this section is published each year in the January issue. The current list, which includes contact information for each title, appears on page 164 of the January 2006 issue. Readers who want information about any article or publication appearing in New in Review should use this directory to locate the authors or editors of the original article or publication. AMERICAN FAMILY PHYSICIAN Vol 73, June 1, 2006 (www.aafp.org/afp) Œ
Œ
Low-Carbohydrate Diets. (Review). Last AR, Wilson SA. 1942-1948. Inborn Errors of Metabolism in Infancy and Early Childhood: An Update. (Review). Raghuveer TS, Garg U, Graf WD. 1981-1990.
AMERICAN HEART JOURNAL Vol 151, June 2006 (www.mosby.com/ahj) Œ
Comparison of the Serum Ferritin and Percentage of Transferrin Saturation as Exposure Markers of Iron-Driven Oxidative StressRelated Disease Outcomes. Lee
Œ
Œ
Œ
●
●
Probiotic Use in Clinical Practice: What Are the Risks? (Review). Boyle RJ, Robins-Browne RM, Tang ML. 1256-1264. Carotenoids and Cardiovascular Health (Review). Voutilainen S, Nurmi T, Mursu J, Rissanen TH. 1265-1271. From Nutrition Scientist to Nutrition Communicator: Why You Should Take the Leap. (Commentary). Miller GH, Cohen NL, Fulgoni VL, Heymsfield SB, Wellman NS. 1272-1275. Effect of Satiety on Brain Activation during Chocolate Tasting in Men and Women. Smeets PA, de Graaf C, Stafleu A, van Osch MJ, Nievelstein RA, van der Grond J. 1297-1305. Effect of n-3 Long-Chain Polyunsaturated Fatty Acid Supplementation of Women with Low-Risk Pregnancies on Pregnancy Outcomes and Growth Measures at Birth: A MetaAnalysis of Randomized Controlled Trials. (Meta-Analysis). Szajewska H, Horvath A, Koletzko B. 13371344. Additive Effects of Moderate Drinking and Obesity on Serum ␥–Glutamyl Transferase Activity. Puukka K, Hietala J, Koivisto H, Anttila P, Bloigu R, Niemela O. 1351-1354.
Meta-analysis of fatty acids in pregnancy. A cohort of studies has been published examining the effect of n-3 polyunsaturated fatty acid (PUFA) supplementation in pregnancy with variable results. This study group conducted a meta-analysis to quantify the pregnancy outcomes and fetal growth changes with PUFA supplementation. A detailed inclusion search strategy identified randomized clinical trials and quasi-randomized clinical trials comparing PUFA supplementation with placebo or control groups in normal pregnancy situations that reported birth outcomes
© 2006 by the American Dietetic Association
published in a peer-reviewed journal. A manual quality index of each study was independently performed by each of two investigators and compared for discrepancy. Data were extracted to standardized forms and transferred to REVMAN software (version 4.2, 2005, Cochrane Collaboration, Oxford, UK) for analysis. Both a fixed and random effects model approach were used, fitted to the heterogeneity and Cochrane’s Q statistic. Publication bias was assessed by funnel plot. Initially, 21 randomized clinical trials were identified; six met inclusion criteria (n⫽1,278). Dose and duration of PUFA supplementation varied between trials from 200 mg/d to 1,000 mg/d. Results showed the PUFA supplementation (n⫽640) compared to placebo or control (n⫽638) was associated with slightly longer pregnancy duration (1.57 days) but no other differences in preterm delivery, placental weight, or common complications (gestational diabetes, eclampsia). Infant outcome of PUFA supplementation resulted in no detectable differences in birth-weight or length. The slight increase in head circumference seen in four of the randomized clinical trials did not prevail after the sensitivity analysis or was related to PUFA supplementation amount. The mean effect size of PUFA supplementation was small and nonsignificant, but nondetrimental to mother and infant. No funding source was identified. Additive effects of drinking and obesity. The biological marker, ␥– glutamyl transferase (GGT), is used to estimate liver injury due to chronic ethanol, drug, or xenobiotic use and to indirectly predict nutritional risk. The database from a large cohort sample of healthy Nordic adults (n⫽2,490, 48% men, mean age 47 years), originally collected for serum enzyme reference standards, was used. Data were also available on selfreported alcohol consumption patterns, alcohol consumption in the 24 hours prior to the blood sample, anthropometrics, and smoking. Pearson product correlations were used to assess relationship between GGT, alcohol consumption, and body weight
Journal of the AMERICAN DIETETIC ASSOCIATION
1497
*/52.!, /&